1. Voice-Related Quality of Life After Treatment of Laryngeal Cancer
- Author
-
Noriko Nishizawa, Hiromitsu Hatakeyama, Satoshi Fukuda, Fumiyuki Suzuki, Nobuhiko Oridate, Yasushi Furuta, Akihiro Homma, Yuji Nakamaru, Seigo Suzuki, Tomohiro Sakashita, and Shigenari Taki
- Subjects
Male ,Laser surgery ,Pediatrics ,medicine.medical_specialty ,medicine.medical_treatment ,MEDLINE ,Laryngectomy ,Malignancy ,Quality of life ,Surveys and Questionnaires ,medicine ,Humans ,Laryngeal Neoplasms ,Aged ,Aged, 80 and over ,Voice Disorders ,business.industry ,Cancer ,General Medicine ,Middle Aged ,medicine.disease ,Surgery ,Radiation therapy ,Otorhinolaryngology ,Chemotherapy, Adjuvant ,Carcinoma, Squamous Cell ,Quality of Life ,Female ,Radiotherapy, Adjuvant ,Laser Therapy ,business ,Chemoradiotherapy - Abstract
Objective To determine patient-perceived voice-related quality of life in patients treated with various methods based on the results of Voice-Related Quality of Life (VRQOL) and Voice Handicap Index-10 (VHI-10) questionnaires. Design The VRQOL and VHI-10 questionnaires. Setting University hospital. Patients One hundred thirty-seven patients who had received definitive treatment of laryngeal cancer were followed-up at Hokkaido University Hospital, Sapporo, Japan, and were alive with no evidence of malignancy at the time of the survey. Main Outcome Measure Patient-perceived voice-related quality of life based on the results of the VRQOL and VHI-10 questionnaires. Results The mean VRQOL scores for patients who had undergone radiotherapy (n = 63), chemoradiotherapy (n = 29), laser surgery (n = 14), or total laryngectomy (n = 27) as final treatment of laryngeal cancer were 92.6, 92.9, 85.5, and 68.4, respectively; the mean VHI-10 scores were 2.87, 2.34, 5.43, and 11.26, respectively. Conclusion The VRQOL and VHI-10 questionnaires are important in judging the overall effectiveness of treatment options for laryngeal cancer.
- Published
- 2009
- Full Text
- View/download PDF